Target intelligence / Profile preview

Actin gamma 1 pseudogene 9 (ACTG1P9)

Target: ACTG1P9
Molecular classification: Pseudogene

Overview

Actin gamma 1 pseudogene 9 (ACTG1P9) is a non-functional gene segment related to the ACTG1 gene, mapped to human chromosome 6p21[5]. Like other pseudogenes, ACTG1P9 typically arises from gene duplication or retrotransposition events and does not encode a functional RNA or protein product. There is no evidence for its involvement in cellular function, disease, or drug response, and it has not been described as a relevant therapeutic target in biomedical research. The canonical ACTG1 gene encodes actin gamma 1, a key cytoskeletal protein, but ACTG1P9 is not involved in those functions.

Biological functions

No known biological function (pseudogene)

Disease associations

None reported

Beyond the preview

Go deeper on Actin gamma 1 pseudogene 9 (ACTG1P9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin gamma 1 pseudogene 9 (ACTG1P9).

Explore the full profile